🚀 VC round data is live in beta, check it out!
Fractyl Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Fractyl Health and similar public comparables like InflaRx, NRX Pharmaceuticals, Valerio Therapeutics, Synthaverse and more.
Fractyl Health Overview
About Fractyl Health
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Founded
2010
HQ
Employees
107
Website
Financials (LTM)
EV
$55M
Fractyl Health Financials
Fractyl Health reported last 12-month revenue of — and negative EBITDA of ($91M).
In the same LTM period, Fractyl Health generated — in gross profit, ($91M) in EBITDA losses, and had net loss of ($129M).
Revenue (LTM)
Fractyl Health P&L
In the most recent fiscal year, Fractyl Health reported revenue of — and EBITDA of ($92M).
Fractyl Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | ($91M) | XXX | ($92M) | XXX | XXX | XXX |
| Net Profit | ($129M) | XXX | ($141M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Fractyl Health Stock Performance
Fractyl Health has current market cap of $75M, and enterprise value of $55M.
Market Cap Evolution
Fractyl Health's stock price is $0.47.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $55M | $75M | 1.7% | XXX | XXX | XXX | $-0.89 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFractyl Health Valuation Multiples
Fractyl Health trades at (0.6x) EV/EBITDA.
EV / Revenue (LTM)
Fractyl Health Financial Valuation Multiples
As of April 11, 2026, Fractyl Health has market cap of $75M and EV of $55M.
Equity research analysts estimate Fractyl Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fractyl Health has a P/E ratio of (0.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $75M | XXX | $75M | XXX | XXX | XXX |
| EV (current) | $55M | XXX | $55M | XXX | XXX | XXX |
| EV/EBITDA | (0.6x) | XXX | (0.6x) | XXX | XXX | XXX |
| EV/EBIT | (0.6x) | XXX | (0.6x) | XXX | XXX | XXX |
| P/E | (0.6x) | XXX | (0.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Fractyl Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Fractyl Health Margins & Growth Rates
Fractyl Health's revenue in the last fiscal year declined by (100%).
Fractyl Health's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.9M for the same period.
Fractyl Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Growth | (7%) | XXX | (3%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.9M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Fractyl Health Public Comps
See public comps and valuation multiples for other Biopharmaceuticals and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| InflaRx | XXX | XXX | XXX | XXX | XXX | XXX |
| NRX Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Valerio Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Synthaverse | XXX | XXX | XXX | XXX | XXX | XXX |
| BeyondSpring | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fractyl Health M&A Activity
Fractyl Health acquired XXX companies to date.
Last acquisition by Fractyl Health was on XXXXXXXX, XXXXX. Fractyl Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Fractyl Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFractyl Health Investment Activity
Fractyl Health invested in XXX companies to date.
Fractyl Health made its latest investment on XXXXXXXX, XXXXX. Fractyl Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Fractyl Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Fractyl Health
| When was Fractyl Health founded? | Fractyl Health was founded in 2010. |
| Where is Fractyl Health headquartered? | Fractyl Health is headquartered in United States. |
| How many employees does Fractyl Health have? | As of today, Fractyl Health has over 107 employees. |
| Who is the CEO of Fractyl Health? | Fractyl Health's CEO is Harith Rajagopalan. |
| Is Fractyl Health publicly listed? | Yes, Fractyl Health is a public company listed on Nasdaq. |
| What is the stock symbol of Fractyl Health? | Fractyl Health trades under GUTS ticker. |
| When did Fractyl Health go public? | Fractyl Health went public in 2024. |
| Who are competitors of Fractyl Health? | Fractyl Health main competitors are InflaRx, NRX Pharmaceuticals, Valerio Therapeutics, Synthaverse. |
| What is the current market cap of Fractyl Health? | Fractyl Health's current market cap is $75M. |
| Is Fractyl Health profitable? | No, Fractyl Health is not profitable. |
| What is the current EBITDA of Fractyl Health? | Fractyl Health has negative EBITDA and is not profitable. |
| What is the current EV/EBITDA multiple of Fractyl Health? | Current EBITDA multiple of Fractyl Health is (0.6x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.